Journal of Personalized Medicine (Oct 2023)

Vasopressin in Sepsis and Other Shock States: State of the Art

  • Raquel García-Álvarez,
  • Rafael Arboleda-Salazar

DOI
https://doi.org/10.3390/jpm13111548
Journal volume & issue
Vol. 13, no. 11
p. 1548

Abstract

Read online

This review of the use of vasopressin aims to be comprehensive and highly practical, based on the available scientific evidence and our extensive clinical experience with the drug. It summarizes controversies about vasopressin use in septic shock and other vasodilatory states. Vasopressin is a natural hormone with powerful vasoconstrictive effects and is responsible for the regulation of plasma osmolality by maintaining fluid homeostasis. Septic shock is defined by the need for vasopressors to correct hypotension and lactic acidosis secondary to infection, with a high mortality rate. The Surviving Sepsis Campaign guidelines recommend vasopressin as a second-line vasopressor, added to norepinephrine. However, these guidelines do not address specific debates surrounding the use of vasopressin in real-world clinical practice.

Keywords